Phillip L. Pearl

Phillip L. Pearl is an American child neurologist, epileptologist, educator, and musician. He is currently the Director of the Epilepsy and Clinical Neurophysiology Division and William G. Lennox Chair in the Department of Neurology at Boston Children's Hospital, and Professor of Neurology at Harvard Medical School.

He is known for his research on inherited metabolic epilepsies, particularly disorders of GABA metabolism such as succinic semialdehyde dehydrogenase deficiency (SSADHD). He is also active in the intersection of medicine and music and is affiliated with the Berklee College of Music's Music and Health Institute.

Biography Originally from Baltimore, Pearl studied natural sciences at Johns Hopkins University, where he earned his undergraduate degree with honors in 1980. He received his medical degree from the University of Maryland School of Medicine in 1984.

He then undertook fellowship training in clinical neurophysiology and epilepsy at Boston Children's Hospital and Beth Israel Deaconess Medical Center, affiliated with Harvard Medical School. He served as Director of Medical Student Education in Neurology at George Washington University (GWU) from 2002-2013, Child Neurology Program Director at Children's National Medical Center from 2002-2011, and Division Chief of Child Neurology from 2011-2013.

In 2014, Pearl joined Boston Children's Hospital as Director of the Epilepsy and Clinical Neurophysiology Division and the William G. Lennox Chair in the Department of Neurology and was appointed Professor of Neurology at Harvard Medical School.

His academic work expanded to include Director of the Harvard Medical School Leadership Program in Pediatrics and visiting professorships throughout the US and world. He currently serves on the board of the International Child Neurology Association. In collaboration with K. Michael Gibson PhD, he helped define clinical and neurophysiological features of the disorder and has maintained NIH research funding since 2004. He is currently the Principal Investigator on the NIH supported natural history study of the disorder.

He has written or edited eight books one translated into Chinese and another into Japanese, and is currently a member of the Music and Health Institute at Berklee College of Music.

He has presented internationally on the neurological conditions of historical musicians and regularly integrates music into his teaching and public lectures.

His debut CD, Live at Jazzmatazz, was recorded at Blues Alley Jazz Club, with proceeds having supported pediatric care.

Pediatric Epilepsy Syndromes and Classification A central focus of Pearl's work is the classification and characterization of pediatric epilepsy syndromes. His research emphasizes the importance of age-specific syndromic frameworks, clinical-electrographic correlations, and prognosis-based diagnosis. By refining how epilepsy syndromes are identified in neonates, infants, and children, he has helped clinicians better predict disease progression and tailor treatment strategies.

Metabolic and Treatable Epilepsies Pearl also identify metabolic and vitamin-responsive epilepsies that are potentially reversible. His research highlights disorders such as pyridoxine-dependent epilepsy and other metabolic abnormalities where early diagnosis can dramatically improve patient outcomes. By promoting metabolic screening and awareness of treatable causes, he has shifted clinical practice toward early intervention, reducing long-term neurological damage in affected children.

Genetic and Precision Medicine in Epilepsy Pearl research also focus on precision medicine approaches in epilepsy. His work explores the genetic basis of epilepsy, including mutations affecting ion channels and metabolic pathways. By integrating genomic data into clinical practice, he supports individualized treatment strategies that move beyond symptomatic control toward targeting underlying causes. This research contributes to the broader transformation of epilepsy care into a personalized, mechanism-based discipline.

Neurophysiology and EEG-Based Research Pearl has contributed to the use of electroencephalography (EEG) in epilepsy diagnosis and management. His work involves analyzing seizure patterns, identifying biomarkers, and improving pre-surgical evaluations for drug-resistant epilepsy. Through these efforts, he has enhanced the role of EEG as both a diagnostic and prognostic tool, aiding in more precise clinical decision-making.

Therapeutic in Epilepsy Pearl's research also encompasses the development and evaluation of therapeutic strategies for epilepsy. He has contributed to pharmacological advancements by studying antiepileptic drugs in pediatric populations, ensuring both safety and efficacy. In addition, he has explored metabolic therapies such as ketogenic diets and their interaction with genetic epilepsies. His work extends to emerging treatments, including gene-based therapies and targeted interventions for inherited metabolic disorders, promoting a multimodal approach to epilepsy care.

Rare Neurological Disorders and Orphan Diseases Another important area of Pearl's work involves rare and orphan neurological diseases. Through collaborations with international organizations and research networks, he has contributed to improving the diagnosis and understanding of rare epilepsy syndromes. He has four children and five grandchildren.

Selected publications